Biomatics Capital

Encodia, Inc. raised $75M on January 27, 2021

Investors: ARCH Venture Partners, Tao Capital Partners, Nan Fung Life Sciences, Decheng Capital, Northpond Ventures, GV and Biomatics Capital

Compass Therapeutics LLC raised $61M on July 1, 2020

Investors: F-Prime Capital Partners, OrbiMed Advisors, Borealis Ventures, Thiel Capital and Biomatics Capital

Verve Therapeutics raised $63M on June 11, 2020

Investors: ARCH Venture Partners, F-Prime Capital Partners, Casdin Capital, LLC, GV, Wellington Management and Biomatics Capital

Omniome raised $60M on January 9, 2020

Investors: Decheng Capital, ARCH Venture Partners, Nan Fung Life Sciences, Domain Associates and Biomatics Capital

AiCure raised $25M on November 7, 2019

Investors: Tribeca Venture Partners, Singtel Innov8, New Leaf Venture Partners, Palisades Growth Capital and Biomatics Capital

eGenesis, Inc. raised $100M on November 7, 2019

Investors: 301 Ventures, Khosla Ventures, ARCH Venture Partners, Alta Partners, Wellington Partners, Fresenius Medical Care and Biomatics Capital

BlackThorn Therapeutics raised $76M on June 13, 2019

Investors: Premier Partners, Polaris Partners, GV, ARCH Venture Partners, Scripps, Vertex Ventures HC, Mercury Fund and Biomatics Capital

Thrive, An Exact Sciences Company raised $110M on May 30, 2019

Investors: The Blue Venture Fund, 苏州凯风正德投资管理有限公司, Gamma3 Comunicação e Tecnologia, Exact Sciences, Section 32, Camden Partners, Third Rock Ventures, The Invus Group, Casdin Capital, LLC and Biomatics Capital

DigiSight Technologies, Inc. raised $30M on July 31, 2018

Investors: GE Ventures, Lagunita Biosciences, GV and Biomatics Capital

Omniome raised $60M on July 31, 2018

Investors: Nan Fung Life Sciences, Domain Associates, ARCH Venture Partners, Hillhouse Capital Management, Decheng Capital and Biomatics Capital